Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07813377 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)

Name: Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM) — clinical trial record (NCT07813377)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GliTEM

StatusRecruiting

PhaseNot specified

SponsorFundacion Clinic per a la Recerca Biomédica

Started2026-05-30

View on ClinicalTrials.gov ↗

The objective of our study is to investigate the clinical significance of thromboelastometric values in the development of thrombotic events and survival in patients with glial tumors, to reduce thromboembolic complications and optimize oncological treatment.

Trial Details

NCT Number	NCT07813377
Lead Sponsor	Fundacion Clinic per a la Recerca Biomédica Collaborators: Hospital Clinic of Barcelona
Conditions	Glial Tumors, Thrombosis, Pulmonary Embolism (Diagnosis)
Enrollment	100 participants
Start Date	2026-05-30
Primary Completion	2027-05-30 (estimated)
Study Completion	2027-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-10